FdaApplication

ANDA 065351

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAPOTEX INC
application_typeANDA
approval_date2012-02-29

Products (2)

ProductActive ingredientStrengthDosage form
CEFPROZILCEFPROZIL125MG/5MLFOR SUSPENSION;ORAL
CEFPROZILCEFPROZIL250MG/5MLFOR SUSPENSION;ORAL

2 products